Roubaix Capital LLC Acquires New Holdings in Alpha Teknova, Inc. (NASDAQ:TKNO)

Roubaix Capital LLC purchased a new stake in Alpha Teknova, Inc. (NASDAQ:TKNO - Free Report) during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 416,416 shares of the company's stock, valued at approximately $2,015,000. Roubaix Capital LLC owned about 0.78% of Alpha Teknova as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also recently bought and sold shares of the company. State Board of Administration of Florida Retirement System bought a new stake in shares of Alpha Teknova in the first quarter valued at about $35,000. Redmile Group LLC boosted its holdings in Alpha Teknova by 6.5% in the 1st quarter. Redmile Group LLC now owns 171,453 shares of the company's stock valued at $434,000 after purchasing an additional 10,448 shares during the period. FourWorld Capital Management LLC bought a new position in shares of Alpha Teknova during the first quarter worth approximately $135,000. Finally, Conestoga Capital Advisors LLC raised its position in shares of Alpha Teknova by 81.6% in the second quarter. Conestoga Capital Advisors LLC now owns 453,899 shares of the company's stock valued at $622,000 after buying an additional 203,950 shares in the last quarter. 13.81% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Separately, Stephens restated an "overweight" rating and set a $5.00 price objective on shares of Alpha Teknova in a research note on Wednesday, July 10th.

Alpha Teknova Price Performance

Alpha Teknova stock traded down $0.31 during trading hours on Thursday, reaching $6.80. 208,616 shares of the stock were exchanged, compared to its average volume of 223,680. The stock has a 50 day moving average of $5.28 and a two-hundred day moving average of $3.31. The company has a market cap of $362.46 million, a P/E ratio of -7.31 and a beta of 0.43. The company has a current ratio of 4.76, a quick ratio of 3.28 and a debt-to-equity ratio of 0.16. Alpha Teknova, Inc. has a twelve month low of $1.15 and a twelve month high of $7.49.

Alpha Teknova (NASDAQ:TKNO - Get Free Report) last announced its quarterly earnings data on Tuesday, August 13th. The company reported ($0.13) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.16) by $0.03. The business had revenue of $9.61 million for the quarter, compared to analysts' expectations of $9.50 million. Alpha Teknova had a negative net margin of 98.08% and a negative return on equity of 37.00%. During the same period last year, the firm posted ($0.25) earnings per share. Equities analysts expect that Alpha Teknova, Inc. will post -0.54 EPS for the current fiscal year.

About Alpha Teknova

Alpha Teknova, Inc produces critical reagents for the research, discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification.